Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales39 87421 84820 24720 72221 92723 349
Operating income (EBITDA)12 6164 9745 8625 2265 6906 191
Operating profit (EBIT)9 8334 0464 3143 9964 4654 828
Pre-Tax Profit (EBT)6 2632 521----
Net income5 9632 5762 2844 0763 3053 562
EPS ( $)3,721,621,492,092,152,41
Dividend per Share ( $)1,670,640,900,951,031,12
Yield3,38%1,30%1,82%1,93%2,09%2,27%
Announcement Date01/23/2013
12:47pm
01/22/2014
12:44pm
01/29/2015
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt9 6743 0863 7821 4821 905971
Finance------
Operating income (EBITDA)12 6164 9745 8625 2265 6906 191
Leverage
(Debt/EBITDA)
0,77x0,62x0,65x0,28x0,33x0,16x
Capital Expenditure1 7951 1451 0771 1411 2071 258
Book Value Per Share (BVPS)17,0 $16,3 $14,3 $17,4 $18,5 $19,2 $
Cash Flow per Share5,85 $2,11 $2,41 $3,36 $3,21 $3,61 $
Announcement Date01/23/2013
12:47pm
01/22/2014
12:44pm
01/29/2015
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 73 559 M$ -
Entreprise Value (EV) 75 041 M$ 75 465 M$
Valuation 2015e 2016e
PER (Price / EPS) 23,6x 23,0x
Capitalization / Revenue 3,55x 3,35x
EV / Revenue 3,62x 3,44x
EV / EBITDA 14,4x 13,3x
Yield (DPS / Price) 1,93% 2,09%
Price to book (Price / BVPS) 2,83x 2,67x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 19,3% 20,4%
operating Leverage (Delta EBIT / Delta Sales) - 2,02x
Net Margin (Net Profit / Revenue) 19,7% 15,1%
ROA (Net Profit / Asset) 7,26% 7,86%
ROE (Net Profit / Equities) 13,6% 13,8%
Rate of Dividend 45,6% 48,1%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   5,51% 5,50%
Cash Flow / Sales (Taux d'autofinancement) 24,1% 21,8%
Capital Intensity (Assets / Sales) 2,71x 1,92x
Financial Leverage (Net Debt / EBITDA) 0,28x 0,33x
Price Earning Ratio
EPS & Dividend